Literature DB >> 10747104

Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing.

R Cantón1, M Pérez-Vázquez, A Oliver, B Sánchez Del Saz, M O Gutiérrez, M Martínez-Ferrer, F Baquero.   

Abstract

The Wider system is a newly developed computer-assisted image-processing device for both bacterial identification and antimicrobial susceptibility testing. It has been adapted to be able to read and interpret commercial MicroScan panels. Two hundred forty-four fresh consecutive clinical isolates (138 isolates of the family Enterobacteriaceae, 25 nonfermentative gram-negative rods [NFGNRs], and 81 gram-positive cocci) were tested. In addition, 100 enterobacterial strains with known beta-lactam resistance mechanisms (22 strains with chromosomal AmpC beta-lactamase, 8 strains with chromosomal class A beta-lactamase, 21 broad-spectrum and IRT beta-lactamase-producing strains, 41 extended-spectrum beta-lactamase-producing strains, and 8 permeability mutants) were tested. API galleries and National Committee for Clinical Laboratory Standards (NCCLS) microdilution methods were used as reference methods. The Wider system correctly identified 97.5% of the clinical isolates at the species level. Overall essential agreement (+/-1 log(2) dilution for 3,719 organism-antimicrobial drug combinations) was 95.6% (isolates of the family Enterobacteriaceae, 96.6%; NFGNRs, 88.0%; gram-positive cocci, 95.6%). The lowest essential agreement was observed with Enterobacteriaceae versus imipenem (84.0%), NFGNR versus piperacillin (88.0%) and cefepime (88.0%), and gram-positive isolates versus penicillin (80.4%). The category error rate (NCCLS criteria) was 4.2% (2.0% very major errors, 0.6% major errors, and 1. 5% minor errors). Essential agreement and interpretive error rates for eight beta-lactam antibiotics against isolates of the family Enterobacteriaceae with known beta-lactam resistance mechanisms were 94.8 and 5.4%, respectively. Interestingly, the very major error rate was only 0.8%. Minor errors (3.6%) were mainly observed with amoxicillin-clavulanate and cefepime against extended-spectrum beta-lactamase-producing isolates. The Wider system is a new reliable tool which applies the image-processing technology to the reading of commercial trays for both bacterial identification and susceptibility testing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747104      PMCID: PMC86442     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Evaluation of the autoSCAN-W/A rapid system for identification and susceptibility testing of gram-negative fermentative bacilli.

Authors:  M K York; G F Brooks; E H Fiss
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

Review 2.  Automated systems for identification of microorganisms.

Authors:  C E Stager; J R Davis
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

3.  False resistance to imipenem with a microdilution susceptibility testing system.

Authors:  E J O'Rourke; K G Lambert; K C Parsonnet; A B Macone; D A Goldmann
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

4.  Comparison of the autoSCAN-W/A and Vitek Automicrobic systems for identification and susceptibility testing of bacteria.

Authors:  M R Visser; L Bogaards; M Rozenberg-Arska; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

5.  A critique of semiautomated susceptibility systems.

Authors:  C E Cherubin; R Erg; M Appleman
Journal:  Rev Infect Dis       Date:  1987 May-Jun

6.  Automated interpretation of disk diffusion antibiotic susceptibility tests with the radial profile analysis algorithm.

Authors:  G Hejblum; V Jarlier; J Grosset; A Aurengo
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

7.  Rapid inoculum standardization system: a novel device for standardization of inocula in antimicrobial susceptibility testing.

Authors:  J H Wicks; R L Nelson; G E Krejcarek
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

8.  Prototype of a fully automated device for determination of bacterial antibiotic susceptibility in the clinical laboratory.

Authors:  H D Isenberg; A Reichler; D Wiseman
Journal:  Appl Microbiol       Date:  1971-12

9.  Evaluation of MicroScan rapid panels for detection of high-level aminoglycoside resistance in enterococci.

Authors:  G L Woods; B DiGiovanni; M Levison; P Pitsakis; D LaTemple
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

10.  Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels.

Authors:  R L White; M B Kays; L V Friedrich; E W Brown; J R Koonce
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

View more
  20 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Reidentification of Streptococcus bovis isolates causing bacteremia according to the new taxonomy criteria: still an issue?

Authors:  Beatriz Romero; María-Isabel Morosini; Elena Loza; Mercedes Rodríguez-Baños; Enrique Navas; Rafael Cantón; Rosa Del Campo
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

3.  Long persistence of methicillin-susceptible strains of Staphylococcus aureus causing sepsis in a neonatal intensive care unit.

Authors:  Carmen Gomez-Gonzalez; Concepción Alba; Joaquín R Otero; Francisca Sanz; Fernando Chaves
Journal:  J Clin Microbiol       Date:  2007-05-23       Impact factor: 5.948

4.  Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.

Authors:  Esther Viedma; Carlos Juan; Joshi Acosta; Laura Zamorano; Joaquín R Otero; Francisca Sanz; Fernando Chaves; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

5.  Population analysis and epidemiological features of inhibitor-resistant-TEM-beta-lactamase-producing Escherichia coli isolates from both community and hospital settings in Madrid, Spain.

Authors:  Oihane Martín; Aránzazu Valverde; María I Morosini; Mario Rodríguez-Domínguez; Mercedes Rodríguez-Baños; Teresa M Coque; Rafael Cantón; Rosa del Campo
Journal:  J Clin Microbiol       Date:  2010-05-05       Impact factor: 5.948

6.  Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development.

Authors:  Ana Mena; Virginia Plasencia; Laura García; Olga Hidalgo; José Ignacio Ayestarán; Sebastián Alberti; Nuria Borrell; José L Pérez; Antonio Oliver
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

7.  Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.

Authors:  Carlos Juan; María D Maciá; Olivia Gutiérrez; Carmen Vidal; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

8.  Nosocomial spread of a Staphylococcus hominis subsp. novobiosepticus strain causing sepsis in a neonatal intensive care unit.

Authors:  Fernando Chaves; Mónica García-Alvarez; Francisca Sanz; Concepción Alba; Joaquín R Otero
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

9.  Quality control for beta-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain.

Authors:  Rafael Cantón; Elena Loza; María Del Carmen Conejo; Fernando Baquero; Luis Martínez-Martínez
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients.

Authors:  Olivia Gutiérrez; Carlos Juan; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.